You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Researchers find extending the time between Pfizer doses boosts antibodies

UK researchers have found that extending the time between the first and second doses of the Pfizer/BioNTech COVID-19 vaccine boosted antibodies against all variants of the virus tested compared to a short dosing interval.